Healthcare Resource Utilization for Anemia Management: Current Practice with Erythropoiesis-Stimulating Agents and the Impact of Converting to Once-Monthly C.E.R.A.

Publisher： Karger

E-ISSN： 1421-9735|26|6|537-546

ISSN： 0253-5068

Source： Blood Purification, Vol.26, Iss.6, 2008-11, pp. : 537-546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Time Savings with Once-Monthly C.E.R.A.: A Time and Motion Study Conducted in 13 Haemodialysis Centres in Italy

By  

Blood Purification, Vol. 40, Iss. 2, 2015-08 ,pp. : 173-179

Karger

Access to resources Recommend Favorite

History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology

By  

American Journal of Nephrology, Vol. 45, Iss. 3, 2017-02 ,pp. : 235-247

Karger

Access to resources Recommend Favorite

Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia

By  

Cardiorenal Medicine, Vol. 7, Iss. 3, 2017-04 ,pp. : 188-197

Karger

Access to resources Recommend Favorite

Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen

By  

Nephron Extra, Vol. 1, Iss. 1, 2011-08 ,pp. : 45-54

Karger

Access to resources Recommend Favorite

The Therapeutic Potential of Erythropoiesis-Stimulating Agents for Tissue Protection: A Tale of Two Receptors

By  

Blood Purification, Vol. 29, Iss. 2, 2010-01 ,pp. : 86-92

Karger

Access to resources Recommend Favorite